IHC studies of tumour samples from various stages of colorectal cancer, however, showed that CD59 and CD55 expression is far less frequent than seen with our tumour cell lines (Koretz et al, 1993; Hosch et al, 2001). The gene discussed is CD59; the disease is neoplasm.